CD19 and cancer: The most significant function for this network is cancer, with twelve targets dysregulated over 1.5-fold (ATM, CD19, EGFR, MTA3, PAK4, SRF, STMN1, TFAP2A, HPSE, GADD45B, RDX, and COL1A1) mapped to this network being classified in this disease category with p-values ranging from 5.31 × 10-6 to 1.43 × 10-2.